Ethical Compliance
ZYDUS LIFESCIENCES
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
large
Revenue
1.3%
Debt
0%
Liquidity
3.8%
Revenue
Debt
Liquidity
1.3%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
Other operating revenue | ₹525.90 |
Pharmaceuticals | ₹19,021.50 |
Others | ₹17.50 |
Questionable
INR Crores
Non Compliant
INR Crores
interest & dividend | ₹266.60 |
INR Crores
Revenue from Questionable Sources: | ₹0.00 |
Revenue from Non Compliant Sources: | ₹266.60 |
Total: | ₹266.60 |
Total Revenue: | ₹19,831.50 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹266.60
₹19,831.50
= 1.3%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.